Bayland Capital Leads ~USD10m Series C for China’s SocialMed+ Technology
Source(s): SocialMed+ Technology
Bayland Capital led a ~USD10m Series C for SocialMed+ Technology, a China-based artificial intelligence digital marketing platform focused on the pharmaceutical industry, with follow-on from Long Hill Capital. Read more